HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Login (HMA-DMS)
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Veterinary Medicines
  • >CMDv
  • >Procedural guidance
  • >CMDv Review Procedure and Referrals
  • CMDv
    • About CMDv
    • Implementation of the VMP Regulation
    • COVID-19
    • BREXIT
    • Procedural Contact Points
    • Procedural guidance
      • General Information on Applications
      • Validation of Applications
      • Applications for Marketing Authorisation
      • Post Marketing Procedures
      • CMDv Review Procedure and Referrals
      • Re-examination after DCP/VRA
      • SPC Harmonisation
      • ASMF
      • SPC, Labelling and Package leaflet
      • Miscellaneous
    • Questions & Answers
    • Publications
    • Union Product Database (UPD)
  • VMRI Product Index
  • National Contacts

 

CMDv Review procedure and Referrals

CMDv review procedure - according to Regulation (EU) 2019/6

Standard Operating Procedure for Review procedure (Article 54)

Referrals

Recommendation for MRP after Art. 34 referral (December 2020)

Standard operating procedure for disagreement in procedures - Referral Art. 33(1)

Actions after an opinion from Art. 33(1) CVMP referral

Withdrawal of marketing authorisations for veterinary medicinal products containing zinc oxide

The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. HMA and CMDh/v are in the process of making appropriate changes to this website. If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed. In case you notice information that should be updated, please report this website link using the contact form.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/veterinary-medicines/cmdv/procedural-guidance/cmdv-review-procedure-and-referrals.html